|
|
Volumn 2, Issue 3, 2005, Pages 128-129
|
|
Val-HeFT: Do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?
|
|
Author keywords
Angiotensin II; Angiotensin receptor blocker; Heart failure; Valsartan
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CANDESARTAN;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
LISINOPRIL;
PERINDOPRIL;
PLACEBO;
QUINAPRIL;
VALSARTAN;
ADD ON THERAPY;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CORRELATION FUNCTION;
DIZZINESS;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG POTENTIATION;
ECHOCARDIOGRAPHY;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE SIZE;
HUMAN;
KIDNEY DYSFUNCTION;
MORBIDITY;
MORTALITY;
OPTIMAL DRUG DOSE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RETROSPECTIVE STUDY;
SHORT SURVEY;
SYNCOPE;
TREATMENT OUTCOME;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
ECHOCARDIOGRAPHY;
FEMALE;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HEART VENTRICLES;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
STROKE VOLUME;
SURVIVAL RATE;
TETRAZOLES;
TREATMENT OUTCOME;
VALINE;
|
|
EID: 20444494439
PISSN: 17434297
EISSN: None
Source Type: Journal
DOI: 10.1038/ncpcardio0127 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (3)
|
